Cardiovascular Systems, Inc. (NASDAQ:CSII) Short Interest Update

Cardiovascular Systems, Inc. (NASDAQ:CSIIGet Rating) was the recipient of a significant growth in short interest during the month of October. As of October 31st, there was short interest totalling 1,560,000 shares, a growth of 6.8% from the October 15th total of 1,460,000 shares. Based on an average daily volume of 266,300 shares, the short-interest ratio is currently 5.9 days.

Hedge Funds Weigh In On Cardiovascular Systems

A number of institutional investors and hedge funds have recently added to or reduced their stakes in CSII. Nisa Investment Advisors LLC boosted its stake in shares of Cardiovascular Systems by 54.3% during the 1st quarter. Nisa Investment Advisors LLC now owns 3,495 shares of the medical device company’s stock worth $79,000 after acquiring an additional 1,230 shares in the last quarter. Signaturefd LLC boosted its position in shares of Cardiovascular Systems by 8,110.3% in the first quarter. Signaturefd LLC now owns 2,381 shares of the medical device company’s stock worth $54,000 after buying an additional 2,352 shares during the period. Simplex Trading LLC boosted its position in shares of Cardiovascular Systems by 35.3% in the first quarter. Simplex Trading LLC now owns 9,971 shares of the medical device company’s stock worth $225,000 after buying an additional 2,602 shares during the period. Envestnet Asset Management Inc. acquired a new stake in shares of Cardiovascular Systems in the first quarter worth $833,000. Finally, Russell Investments Group Ltd. boosted its position in shares of Cardiovascular Systems by 17.2% in the first quarter. Russell Investments Group Ltd. now owns 48,564 shares of the medical device company’s stock worth $1,096,000 after buying an additional 7,137 shares during the period. 91.72% of the stock is owned by institutional investors.

Cardiovascular Systems Trading Up 0.7 %

Shares of NASDAQ CSII opened at $14.37 on Friday. The stock’s 50 day moving average price is $13.93 and its two-hundred day moving average price is $14.81. Cardiovascular Systems has a 52-week low of $12.26 and a 52-week high of $26.05. The stock has a market capitalization of $601.84 million, a P/E ratio of -14.37 and a beta of 0.88. The company has a quick ratio of 5.20, a current ratio of 6.22 and a debt-to-equity ratio of 0.08.

Wall Street Analyst Weigh In

Separately, StockNews.com began coverage on Cardiovascular Systems in a report on Wednesday, October 12th. They issued a “hold” rating for the company.

About Cardiovascular Systems

(Get Rating)

Cardiovascular Systems, Inc, a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products.

Recommended Stories

Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.